DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1NITROFURANTOIN
02 1TACROLIMUS
03 1ZIPRASIDONE HYDROCHLORIDE
01 177025
02 177565
03 1206651
01 3No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ZIPRASIDONE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77565
Country : US
Patented : No
Drug : TACROLIMUS
Dosage Form : CAPSULE; ORAL
Application Number : 206651
Country : US
Patented : No
NITROFURANTOIN, MACROCRYSTALLINE
Drug : NITROFURANTOIN
Dosage Form : CAPSULE; ORAL
Application Number : 77025
Country : US
Patented : No
